-
BioGeneration Ventures co-leads €25 million Series A fundraising in NorthSea Therapeutics and its promising NASH drug programma
December 14, 2017BGV co-leads €25 million Series A fundraising in NorthSea Therapeutics and its promising NASH drug programme Lead drug icosabutate,...
0
